National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 10989 [2021-03613]

Download as PDF Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices 747. Catherine Dicus, Tulsa, Oklahoma, Court of Federal Claims No: 21–0780V 748. Sara MacPhee, Washington, District of Columbia, Court of Federal Claims No: 21–0781V 749. Lynn Duclos, Washington, District of Columbia, Court of Federal Claims No: 21–0782V 750. Sean Jiggins, Washington, District of Columbia, Court of Federal Claims No: 21–0783V 751. Sarah Holbrook-Lipscomb on behalf of M.L., Phoenix, Arizona, Court of Federal Claims No: 21–0784V 752. Lebrian Spaugh, Washington, District of Columbia, Court of Federal Claims No: 21–0785V 753. Kathryn Alexander, Englewood, New Jersey, Court of Federal Claims No: 21– 0786V 754. Alane Babington, Wellesley Hills, Massachusetts, Court of Federal Claims No: 21–0789V 755. Naomi Mimnaugh, Wellesley Hills, Massachusetts, Court of Federal Claims No: 21–0790V 756. Robert J. Owens, Sr., Wellesley Hills, California, Court of Federal Claims No: 21–0791V 757. Dayna Higgins, Wellesley Hills, Massachusetts, Court of Federal Claims No: 21–0792V 758. Mary Saville, Washington, District of Columbia, Court of Federal Claims No: 21–0794V 759. Wanda Lange, Houston, Texas, Court of Federal Claims No: 21–0797V 760. Rocelyn Nepomuceno, Boston, Massachusetts, Court of Federal Claims No: 21–0798V 761. Hanna Ozarski, New York, New York, Court of Federal Claims No: 21–0800V 762. Corrine O’Sullivan-Bradley, Rochester, New York, Court of Federal Claims No: 21–0802V 763. Vincent R. Bedogne, Farmington Hills, Michigan, Court of Federal Claims No: 21–0803V 764. Haley Faro, Rochester, New York, Court of Federal Claims No: 21–0805V 765. James Malkin, Boston, Massachusetts, Court of Federal Claims No: 21–0806V 766. Malikia Craddle, Washington, District of Columbia, Court of Federal Claims No: 21–0808V 767. Martha T. Cunningham, Tucson, Arizona, Court of Federal Claims No: 21– 0809V 768. Nabila Gebran, White Plains, New York, Court of Federal Claims No: 21–0810V 769. Bryce Maddox, Englewood, New Jersey, Court of Federal Claims No: 21–0811V 770. Edna Groen, Covington, Kentucky, Court of Federal Claims No: 21–0812V 771. Jeanine John, Seattle, Washington, Court of Federal Claims No: 21–0813V 772. Pete Heffron, Solana Beach, California, Court of Federal Claims No: 21–0814V 773. Fatima Collins, Fort Worth, Texas, Court of Federal Claims No: 21–0815V 774. Linda Garcia, San Antonio, Texas, Court of Federal Claims No: 21–0816V 775. Holly Jenkins, Washington, District of Columbia, Court of Federal Claims No: 21–0819V 776. Danielle Awe, Boston, Massachusetts, VerDate Sep<11>2014 18:36 Feb 22, 2021 Jkt 253001 Court of Federal Claims No: 21–0821V 777. Marlene Koenig-Wiltse, Washington, District of Columbia, Court of Federal Claims No: 21–0822V 778. Edward Tyson, Washington, District of Columbia, Court of Federal Claims No: 21–0823V 779. Marie Galeno, Dresher, Pennsylvania, Court of Federal Claims No: 21–0824V 780. Ramon Pinon, Seattle, Washington, Court of Federal Claims No: 21–0825V 781. Kacy Barker, Boston, Massachusetts, Court of Federal Claims No: 21–0826V 782. Kim Hill, Russellville, Alabama, Court of Federal Claims No: 21–0848V [FR Doc. 2021–03610 Filed 2–22–21; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases Research Committee Microbiology and Infectious Diseases Research Committee (MID). Date: May 26–27, 2021. Time: 10:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G51, Rockville, MD 20892 (Virtual Meeting). Contact Person: Amir E. Zeituni, Ph.D., Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health 5601 Fishers Lane, Room 3G51 Rockville, MD 20852, 301–496–2550, amir.zeituni@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 10989 Dated: February 17, 2021. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–03612 Filed 2–22–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Date: March 22–23, 2021. Time: 10:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G42, Rockville, MD 20892 (Virtual Meeting). Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G42, Rockville, MD 20852, 240–292–0189, sandip.bhattacharyya@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 17, 2021. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–03613 Filed 2–22–21; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\23FEN1.SGM 23FEN1

Agencies

[Federal Register Volume 86, Number 34 (Tuesday, February 23, 2021)]
[Notices]
[Page 10989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03613]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Mucosal Immunology Studies Team 
(MIST) (U01 Clinical Trial Not Allowed).
    Date: March 22-23, 2021.
    Time: 10:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G42, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G42, 
Rockville, MD 20852, 240-292-0189, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 17, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-03613 Filed 2-22-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.